A Rasch analysis for classification of Systemic Lupus Erythematosus and Mixed Connective Tissue Disease

Journal of Applied Measurement

Volumn 9, Issue 2, 2008, Pages 136-150

  Perkins, Kyle ^a   Hoffman, Robert W ^b   Bezruczko, Nikolaus ^c  

^a FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c Measurement and Evaluation Consulting

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLASSIFICATION; FEMALE; HUMAN; MALE; MIDDLE AGED; MIXED CONNECTIVE TISSUE DISEASE; PATHOPHYSIOLOGY; PSYCHOMETRY; QUESTIONNAIRE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AGED; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MIXED CONNECTIVE TISSUE DISEASE; PSYCHOMETRICS; QUESTIONNAIRES;

EID: 44649131363     PISSN: 15297713     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Alarcon-Segovia, D., and Cardiel, M. H. (1989). Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients. The Journal of Rheumatology, 16(3), 328-334.
2. Álvarez, P. (2005). Several noncategorical measures define air pollution construct. In N. Bezruczko (Ed.), Rasch measurement in health sciences (pp. 278-293). Maple Grove, MN: JAM Press.
3. Amigues, J. M., Cantagrel, A., Abbal, M., and Mazieres, B. (1996). Comparative study of 4 diagnosis criteria sets for mixed connective tissue disease in patients with anti-RNP antibodies. Autoimmunity Group of the Hospitals of Toulouse. The Journal of Rheumatology, 23(12), 2055-2062.
4. Aringer, M., Steiner, G., and Smolen, J. S. (2005). Does mixed connective tissue disease exist? Yes. Rheumatic Diseases Clinics of North America, 31(2), 411-420.
5. Bezruczko, N. (2003). Breakthrough measuring socioeconomic status. Journal of Applied Measurement, 4, 137-152.
6. Bezruczko, N. (Ed.). (2005). Rasch measurement in health sciences. Maple Grove, MN: JAM Press.
7. Burdt, M. A., Hoffman, R. W., Deutscher, S. L., Wang, G. S., Johnson, J. C. and Sharp, G. C. (1999). Long-term outcome in mixed connective tissue disease: Longitudinal clinical and serologic findings. Arthritis and Rheumatism, 42(5), 899-909.
8. Cipriani, D., Fox, C., Khuder, S., and Boudreau, N. (2005). Comparing Rasch analyses probability estimates to sensitivity, specificity and likelihood ratios when examining the utility of medical diagnostic tests. Journal of Applied Measurement, 6(2), 180-201.
9. Hoffman, R. W., Cassidy, J. T., Takeda, Y., Smith-Jones, E. I., Wang, G. S., and Sharp, G. C. (1993). U1 -70-kd autoantibody-positive mixed connective tissue disease in children: A longitudinal clinical and serologic analysis. Arthritis and Rheumatism, 36(11), 1599-1602.
10. Hoffman, R. W., and Greidinger, E. L. (2005). Mixed connective tissue disease. Retrieved March 17, 2006, from http://www.emedicine.com/cgi-bin/foxweb. exe/checkreg/em/checkreg? http://www.emedicine.com/med/topic3417.htm
11. Hoffman, R. W., and Sharp, G. C. (1995). Is anti-Ul-RNP autoantibody positive connective tissue disease genetically distinct? The Journal of Rheumatology, 22(4), 586-589.
12. Holyst, M-M., and Hoffman, R. W. (1998). U-small nuclear ribonucleoprotein (RNP)-reactive autoantibodies: Diagnostic testing and clinical interpretation. Clinical Immunology Newsletter, 18(1), 53-57.
13. Hughes, L. F., Perkins, K., Wright, B. D., and Westrick, H. (2003). Using a Rasch scale to characterize the clinical features of patients with a clinical diagnosis of uncertain, probable, or possible Alzheimer Disease at intake. Journal of Alzheimer Disease, 5(5), 367-373.
14. Kasukawa, R., and Sharp, G. C. (Eds). (1987). Mixed connective tissue disease and antinuclear antibodies. Proceedings of the international symposium on Mixed Connective Tissue Disease and Anti-nuclear Antibodies. New York: Excerpta Medica.
15. Linacre, J. M. (1997). Instantaneous measurement and diagnosis. Physical Medicine and Rehabilitation State of the Art Reviews, 11(2), 315-324.
16. Linacre, J. M. (1998). Detecting multidimension-ality. Which residual-type works best? Journal of Outcome Measurement, 2, 266-283.
17. Linacre, J. M. (1999). Understanding Rasch measurement: Estimation methods for Rasch measures. Journal of Outcome Measurement, 3, 382-405.
18. Linacre, J. M. (2006). WINSTEPS: Rasch analysis [Computer program]. Chicago: MESA Press.
19. Miller, A., Wilbur, J., Montgomery, A., Chandler, and Bezruczko, N. (2001). Measurement properties of symptom impact inventory. Journal of Outcome Measurement, 4, 763-793.
20. Perkins, K., Wright, B. D., and Dorsey, J. K. (2005). Using Rasch measurement with medical data. In N. Bezruczko (Ed.), Rasch measurement in health sciences (pp. 221-234). Maple Grove, MN: JAM Press.
21. Porter, J. F., Kingsland, L. C., III, Lindberg, D. A., Shah, I., Benge, J. M., Hazelwood, S. E., et al. (1988). The AI/RHEUM knowledge-based computer consultant system in rheumatology. Performance in the diagnosis of 59 connective tissue disease patients from Japan. Arthritis and Rheumatism, 31(2), 219-226.
22. Sharp, G. C., Irvin, W. S., Tan, E. M., Gould, R. G., and Holman, H. R. (1972). Mixed connective tissue disease - an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). The American Journal of Medicine, 52(2), 148-159.
23. Smith, R. M. (1996). A comparison of methods for determining dimensionality in Rasch measurement. Structural Equation Modeling, 3(1), 25-40.
24. Sullivan, W. D., Hurst, D. J., Harmon, C. E., Esther, J. H., Agia, G. A., Maltby, J. D., et al. (1984). A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease. Medicine, 63(2), 92-107.
25. Swanton, J., and Isenberg, D. (2005). Mixed connective tissue disease: Still crazy after all these years. Rheumatic Diseases Clinics of North America, 31 (3), 421-436.
26. Wright, B. D. (1996). Comparing Rasch measurement and factor analysis. Structural Equation Modeling, 3(1), 3-24.
27. Wright, B. D., and Stone, M. H. (1979). Best test design. Chicago: MESA Press.